Skip to main content
OpenTrials
Completed

NCT Number: NCT01251419

The Impact of Social Proximity on Conversion to Generic Prescription Medications

The goal of this project is to understand the effects of receiving peer information on individuals' conversion rates from brand name prescription medication to generic prescription medication.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Express Scripts

St Louis, Missouri, 63121, United States

About this study

At companies where employees are predominantly union members, we will compare the efficacy of a peer information intervention using a testimonial from a union identified employee to an intervention using a testimonial with no union identification, as well as to a no-testimonial intervention.

The control arm will receive a letter signed by our partner company's Chief Medical Officer, explaining the health and monetary benefits of switching from brand name prescription medication to generic prescription medication. The testimonial treatment arm will receive the exact same letter, but the letter will feature an employee's testimonial along with the first name, last initial, city and state of the employee giving the testimonial. The testimonial and union arm will receive the same letter as the testimonial treatment arm but with the addition of the union affiliation of the employee giving the testimonial.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Employee of a company that uses Express Scripts as its pharmacy benefits manager.
  • Employee at a company with predominantly union employees.
  • Currently taking a brand name medication with an exact generic equivalent.

Exclusion criteria

  • Employees on any psychological prescription medication.

Treatment and study plan

Social Proximity and Conversion to Generic Medications

Other

At companies where employees are predominantly union members, we will compare the efficacy of a peer information intervention using a testimonial from a union identified employee to an intervention using a testimonial with no union identification, as well as to a no-testimonial intervention.

Primary outcomes

  1. Conversion from Brand Name to Generic Prescription Medication

    Time frame: One month to one year after the intervention.

    We will measure conversion rates of employees from brand name to generic prescription medication by treatment arm.

Secondary outcomes

  1. Union Status and Conversation to Generic Medication

    Time frame: One month to one year after the intervention.

    We will see how union affiliation affects the employee conversion rates from brand name to prescription medication by treatment arm.

Sponsors and collaborators

Lead sponsor

National Bureau of Economic Research, Inc.

Other

Collaborators

  • National Institute on Aging (NIA)

Registry information

Important dates

Study start
2011
Primary completion
2012
Study completion
2012
First posted
Dec 1, 2010
Registry last updated
May 18, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.